{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:42:23Z","timestamp":1792208543383,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1245\/s10434-026-20389-7","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:46:26Z","timestamp":1786635986000},"page":"10750-10759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overall and Cause-Specific Late Mortality in Long-Term Survivors of Early Onset Solid Cancer After Surgery: A Population-Based Retrospective Cohort Study"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-2360","authenticated-orcid":false,"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"20389_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/pubmed\/fdaf088","volume":"47","author":"S Kim","year":"2025","unstructured":"Kim S, Keum N. Global trends in early-onset and late-onset cancer incidence. J Public Health (Oxf). 2025;47:699\u2013709.","journal-title":"J Public Health (Oxf)"},{"key":"20389_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, Sasamoto N, Lee HY, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19:656\u201373.","journal-title":"Nat Rev Clin Oncol"},{"key":"20389_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.annonc.2024.08.2336","volume":"35","author":"S Ogino","year":"2024","unstructured":"Ogino S, Ugai T. The global epidemic of early-onset cancer: nature, nurture. Or Both Ann Oncol. 2024;35:1071\u20133.","journal-title":"Or Both. Ann Oncol"},{"key":"20389_CR4","first-page":"79","volume":"12","author":"M Terashima","year":"2025","unstructured":"Terashima M, Nakayama K, Shirai S, et al. Diverging global incidence trends of early-onset cancers: comparisons with incidence trends of later-onset cancers and mortality trends of early-onset cancers. Mil Med Res. 2025;12:79.","journal-title":"Mil Med Res"},{"key":"20389_CR5","doi-asserted-by":"publisher","first-page":"1714359","DOI":"10.3389\/fpubh.2026.1714359","volume":"14","author":"Q Yin","year":"2026","unstructured":"Yin Q, Xu R, Wang D, Li J. Prevalence and trends in long-term survivors of early-onset versus late-onset cancer: a serial cross-sectional study. Front Public Health. 2026;14:1714359.","journal-title":"Front Public Health"},{"key":"20389_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1200\/JCO.23.01751","volume":"42","author":"Sh Armenian","year":"2024","unstructured":"Armenian Sh, Chao C. Burden of morbidity and mortality in adolescent and young adult cancer survivors. J Clin Oncol. 2024;42:735\u201342.","journal-title":"J Clin Oncol"},{"key":"20389_CR7","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(22)02471-0","volume":"401","author":"SB Dixon","year":"2023","unstructured":"Dixon SB, Liu Q, Chow EJ, et al. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the childhood cancer survivor study cohort. Lancet. 2023;401:1447\u201357.","journal-title":"Lancet"},{"key":"20389_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1470-2045(19)30800-9","volume":"21","author":"E Suh","year":"2020","unstructured":"Suh E, Stratton KL, Leisenring WM, et al. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the childhood cancer survivor study. Lancet Oncol. 2020;21:421\u201335.","journal-title":"Lancet Oncol"},{"key":"20389_CR9","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/S2468-2667(24)00268-8","volume":"10","author":"T Hughes","year":"2025","unstructured":"Hughes T, Diaz RL, Mckillop S, Nathan PC, Fidler-Benaoudia MM. Overall and late mortality among 24 459 survivors of adolescent and young adult cancer in Alberta, Canada: a population-based cohort study. Lancet Public Health. 2025;10:e36\u201346.","journal-title":"Lancet Public Health"},{"key":"20389_CR10","doi-asserted-by":"publisher","first-page":"E2255395","DOI":"10.1001\/jamanetworkopen.2022.55395","volume":"6","author":"MJ Ehrhardt","year":"2023","unstructured":"Ehrhardt MJ, Liu Q, Dixon SB, et al. Association of modifiable health conditions and social determinants of health with late mortality in survivors of childhood cancer. Jama Netw Open. 2023;6:E2255395.","journal-title":"Jama Netw Open"},{"key":"20389_CR11","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/cncr.32775","volume":"126","author":"SH Armenian","year":"2020","unstructured":"Armenian SH, Xu L, Cannavale KL, Wong FL, Bhatia S, Chao C. Cause-specific mortality in survivors of adolescent and young adult cancer. Cancer. 2020;126:2305\u201316.","journal-title":"Cancer"},{"key":"20389_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jama.2010.923","volume":"304","author":"RC Reulen","year":"2010","unstructured":"Reulen RC, Winter DL, Frobisher C, et al. Long-term cause-specific mortality among survivors of childhood cancer. Jama. 2010;304:172\u20139.","journal-title":"Jama"},{"key":"20389_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ijc.30080","volume":"139","author":"M Schindler","year":"2016","unstructured":"Schindler M, Spycher BD, Ammann RA, et al. Cause-specific long-term mortality in survivors of childhood cancer in Switzerland: A population-based study. Int J Cancer. 2016;139:322\u201333.","journal-title":"Int J Cancer"},{"key":"20389_CR14","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572\u201382.","journal-title":"N Engl J Med"},{"key":"20389_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrc2349","volume":"8","author":"A Bleyer","year":"2008","unstructured":"Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008;8:288\u201398.","journal-title":"Nat Rev Cancer"},{"key":"20389_CR16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s43018-024-00733-0","volume":"5","author":"P De Blank","year":"2024","unstructured":"De Blank P, Lange KR, Xing M, et al. Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood Glioma: a report from the childhood cancer survivor study. Nat Cancer. 2024;5:590\u2013600.","journal-title":"Nat Cancer"},{"key":"20389_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/cancers9090120","volume":"9","author":"V Verma","year":"2017","unstructured":"Verma V, Simone CB 2nd, Werner-Wasik M. Acute and late toxicities of concurrent chemoradiotherapy for locally-advanced non-small cell lung cancer. Cancers (Basel). 2017;9:120.","journal-title":"Cancers (Basel)"},{"key":"20389_CR18","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.3390\/ijms26115401","volume":"26","author":"J Daher","year":"2025","unstructured":"Daher J, Rizza A, Tonacci A, Borghini A. A comprehensive review of radiotherapy-induced coronary artery disease-epidemiology, biological mechanisms, and preventive strategies. Int J Mol Sci. 2025;26:5401.","journal-title":"Int J Mol Sci"},{"key":"20389_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jamaoncol.2018.5625","volume":"5","author":"LM Morton","year":"2019","unstructured":"Morton LM, Dores GM, Schonfeld SJ, et al. Association of chemotherapy for solid tumors with development of therapy-related myelodysplastic syndrome or acute myeloid leukemia in the modern era. Jama Oncol. 2019;5:318\u201325.","journal-title":"Jama Oncol"},{"key":"20389_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","volume":"12","author":"AB De Gonzalez","year":"2011","unstructured":"De Gonzalez AB, Curtis RE, Kry SF, et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the us seer cancer registries. Lancet Oncol. 2011;12:353\u201360.","journal-title":"Lancet Oncol"},{"key":"20389_CR21","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1093\/jnci\/djaf268","volume":"117","author":"MA Dinan","year":"2025","unstructured":"Dinan MA, Stratton KL, Leisenring WM, et al. Treatment exposure-based risk-stratification for care of survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2025;117:2580\u201390.","journal-title":"J Natl Cancer Inst"},{"key":"20389_CR22","doi-asserted-by":"crossref","unstructured":"Gbd 2021 Risk factors collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2162-203.","DOI":"10.1016\/S0140-6736(24)00933-4"},{"key":"20389_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1574892814666190102122848","volume":"14","author":"A Santoro","year":"2019","unstructured":"Santoro A, Tomino C, Prinzi G, et al. Tobacco smoking: risk to develop addiction, chronic obstructive pulmonary disease, and lung cancer. Recent Pat Anticancer Drug Discov. 2019;14:39\u201352.","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"20389_CR24","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s11764-023-01514-x","volume":"19","author":"M Leske","year":"2025","unstructured":"Leske M, Galanis C, Koczwara B, Beatty L. A meta-analysis of healthy lifestyle interventions addressing quality of life of cancer survivors in the post treatment phase. J Cancer Surviv. 2025;19:940\u201356.","journal-title":"J Cancer Surviv"},{"key":"20389_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1200\/JCO.24.00342","volume":"43","author":"KE Weaver","year":"2025","unstructured":"Weaver KE, Dressler EV, Klepin HD, et al. Effectiveness of a cardiovascular health electronic health record application for cancer survivors in community oncology practice: results from Wf-1804cd. J Clin Oncol. 2025;43:46\u201356.","journal-title":"J Clin Oncol"},{"key":"20389_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10495-025-02199-6","volume":"31","author":"J Luo","year":"2026","unstructured":"Luo J, Su J, Xia C. Cardiotoxicity induced by traditional chemotherapy: mechanisms and mitigation strategies. Apoptosis. 2026;31:16.","journal-title":"Apoptosis"},{"key":"20389_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11701-024-01832-x","volume":"18","author":"JP Micha","year":"2024","unstructured":"Micha JP, Rettenmaier MA, Bohart RD, Goldstein BH. Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer. J Robot Surg. 2024;18:80.","journal-title":"J Robot Surg."},{"key":"20389_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41571-026-01123-4","volume":"23","author":"DB Johnson","year":"2026","unstructured":"Johnson DB, Nassar AH, Aijaz A, Knight A, Zerey MM, Rini BI, et al. Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization. Nat Rev Clin Oncol. 2026;23:341\u201355.","journal-title":"Nat Rev Clin Oncol."},{"key":"20389_CR29","doi-asserted-by":"publisher","first-page":"153303382513336","DOI":"10.1177\/15330338251333658","volume":"24","author":"A Katano","year":"2025","unstructured":"Katano A. Exploring the current challenges and pioneering clinical applications of stereotactic radiotherapy in cancer treatment. Technol Cancer Res Treat. 2025;24:15330338251333658.","journal-title":"Technol Cancer Res Treat"},{"key":"20389_CR30","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1158\/1055-9965.EPI-25-0201","volume":"34","author":"M Rebolj","year":"2025","unstructured":"Rebolj M, Brentnall AR, Geppert J, Kouppa N, Shinkins B, Freeman K, et al. Late-stage outcomes as surrogates for mortality in cancer screening trials: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2025;34:1694\u2013709.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"20389_CR31","first-page":"CD012425","volume":"2019","author":"BL H\u00f8eg","year":"2019","unstructured":"H\u00f8eg BL, Bidstrup PE, Karlsen RV, Friberg AS, Albieri V, Dalton SO, et al. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev. 2019;2019(11):CD012425.","journal-title":"Cochrane Database Syst Rev"},{"key":"20389_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejca.2022.07.025","volume":"174","author":"B Galjart","year":"2022","unstructured":"Galjart B, H\u00f6ppener DJ, Aerts J, Bangma CH, Verhoef C, Gr\u00fcnhagen DJ. Follow-up strategy and survival for five common cancers: a meta-analysis. Eur J Cancer. 2022;174:185\u201399.","journal-title":"Eur J Cancer"},{"key":"20389_CR33","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamasurg.2024.1753","volume":"159","author":"JH Lee","year":"2024","unstructured":"Lee JH, Kim J, Choi JY. Feasibility of extended postoperative follow-up in patients with gastric cancer. Jama Surg. 2024;159:1009\u201317.","journal-title":"Jama Surg"},{"key":"20389_CR34","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/eurheartj\/ehaf100","volume":"46","author":"SC Adams","year":"2025","unstructured":"Adams SC, Rivera-Theurel F, Scott JM, Nadler MB, Foulkes S, Leong D, et al. Cardio-oncology rehabilitation and exercise: evidence, priorities, and research standards from the icos-core working group. Eur Heart J. 2025;46:2847\u201365.","journal-title":"Eur Heart J."},{"key":"20389_CR35","doi-asserted-by":"publisher","unstructured":"Hundal J, Peshin S, Ghazanfar R, Hayes S, Mansfield S, Sirotin N, et al. Implementing lifestyle medicine in cancer survivorship: a narrative review of global models. Am J Lifestyle Med. 2025;12. https:\/\/doi.org\/10.1177\/15598276251359525","DOI":"10.1177\/15598276251359525"},{"key":"20389_CR36","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1186\/s12885-025-15063-2","volume":"25","author":"SH Booij","year":"2025","unstructured":"Booij SH, Pieper A, Wester CD, B\u00fcltmann U, Waarsenburg EC, Hoenders H. The transdiagnostic oncology program (Top): a multidomain lifestyle intervention to improve the quality of life of cancer survivors - a before-and-after pilot study in primary care. Bmc Cancer. 2025;25:1745.","journal-title":"Bmc Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20389-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:24:51Z","timestamp":1792207491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20389-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["20389"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20389-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors claim no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"As a secondary analysis of anonymized data, informed consent and institutional review board approval were not required.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}